Previous 10 | Next 10 |
RedHill Biopharma's Movantik ® Added as Preferred and Unrestricted Brand To Major National Medicare Formulary Serving Millions of Americans Movantik ® approved for inclusion as preferred and unrestricted brand on a major National Medicare Part D formulary s...
RedHill Biopharma Ltd. (RDHL) Q3 2021 Earnings Conference Call Nov 30, 2021 08:30 AM ET Company Participants Alexandra Okmian - Senior Business Development and IR Manager Dror Ben-Asher - CEO Guy Goldberg - Chief Business Officer Gilead Raday - COO Rob Jackson - SVP, Sales and Marketing Micha...
The following slide deck was published by RedHill Biopharma Ltd. in conjunction with their 2021 Q3 earnings call. For further details see: RedHill Biopharma Ltd. 2021 Q3 - Results - Earnings Call Presentation
RedHill (NASDAQ:RDHL): Q3 GAAP EPS of $0.05 beats by $0.27. Revenue of $21.6M (+3.2% Y/Y) misses by $1.8M. Press Release Cash Balance as of September 30, 2021, was $51.5M For further details see: RedHill EPS beats by $0.27, misses on revenue
RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results RedHill Accelerates its Two Advanced COVID-19 Pill Clinical Programs in Light of their Potential Against Omicron Acting independently of spike protein mutation, opaganib and RHB-107's unique h...
RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results Canada NewsWire RedHill Accelerates its Two Advanced COVID-19 Pill Clinical Programs in Light of their Potential Against Omicron Acting independently of spike protein mutation...
RedHill (NASDAQ:RDHL) is scheduled to announce Q3 earnings results on Tuesday, November 30th, before market open. The consensus EPS Estimate is -$0.24 (vs. -$0.05 Y/Y) and the consensus Revenue Estimate is $23.4M (+11.7% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward revisions...
BNED, BNS, BZUN, CHS, JKS, MOMO, RDHL For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Tuesday's open
RedHill Biopharma to Host Third Quarter 2021 Financial Results and Operational Highlights Webcast on November 30, 2021 PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , Nov. 24, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "...
RedHill Biopharma Announces Closing of $15.5 Million Public Offering of American Depositary Shares PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , Nov. 23, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty b...
News, Short Squeeze, Breakout and More Instantly...
Redhill Biopharma Ltd. Company Name:
RDHL Stock Symbol:
NASDAQ Market:
Redhill Biopharma Ltd. Website:
RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien PR Newswire TEL-AVIV, Israel and RALEIGH, NC , July 22, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biophar...
RedHill Biopharma Terminates License Agreement for Aemcolo® PR Newswire TEL-AVIV, Israel and RALEIGH, NC , July 9, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today ...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...